Ann C. Collier

发表

Clinical factors related to brain structure in HIV: the CHARTER study

Terry L. Jernigan, Rebecca J. Theilmann, David M. Simpson, 2011, Journal of NeuroVirology.

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Terry L. Jernigan, Anthony Gamst, David M. Simpson, 2010, Journal of NeuroVirology.

Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection

David C. Nickle, Lawrence Corey, Jianhong Cao, 2006, Journal of Virology.

Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial

Kenneth A. Freedberg, Rochelle P. Walensky, Milton C. Weinstein, 2012, AIDS.

Imaging of Cyclosporine Inhibition of P-Glycoprotein Activity Using 11C-Verapamil in the Brain: Studies of Healthy Humans

Mark Muzi, David A. Mankoff, Jashvant D. Unadkat, 2009, Journal of Nuclear Medicine.

Prevalence and Impact of Minority Variant Drug Resistance Mutations in Primary HIV-1 Infection

Lisa M. Frenkel, A. Collier, L. Frenkel, 2011, PloS one.

Verapamil P-glycoprotein Transport across the Rat Blood-Brain Barrier: Cyclosporine, a Concentration Inhibition Analysis, and Comparison with Human Data

Mark Muzi, David A. Mankoff, Jashvant D. Unadkat, 2006, Journal of Pharmacology and Experimental Therapeutics.

The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudine

Mark A. Jacobson, Victor De Gruttola, Martin S. Hirsch, 1995, AIDS.

Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1

Chakra Budhathoki, David Katzenstein, James F. Rooney, 2011 .

Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes

Joshua T. Herbeck, Wenjie Deng, Morgane Rolland, 2011, Journal of Virology.